2m 2m 2m 2m 2m 2m 2m
AMYLYX PHARM (AMLX)
NASDAQ
$39.34+$0.68 (+1.76%)
Price as of Aug 21, 2026 7:55 PM EDT- $4.3BMarket Cap
- 315.70%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMYLYX PHARM (AMLX)
$39.34+$0.68 (+1.76%)
AMLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.66 | ||
Change | -$1.00 (-2.52%) | ||
Open | $39.80 | ||
High | $41.14 | ||
Low | $38.35 | ||
Previous Close | $39.66 | ||
Volume | 4,644,894 | ||
30-Day Average Volume | 3,626,525 | ||
1-Week Change | 78.73% | ||
1-Month Change | 108.97% | ||
1-Year Change | 315.70% | ||
3-Year Change | 81.50% | ||
5-Year Change | 302.29% | ||
Fundamentals | |||
Shares Outstanding | 111.4M | ||
Total Assets | $264.6M | ||
Market Cap | $4.3B | ||
Enterprise Value | $4.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$43.4M | ||
Free Cash Flow | -$31.4M | ||
EBIT | -$43.4M | ||
EBITDA | -$43.4M | ||
Net Working Capital | $235.2M | ||
EPS | -$0.39 | ||
Enterprise Value/EBITDA | -98 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 18 | ||
P/E | -99 | ||
PEG | 18 | ||
Price/Free Cash Flow | -137 | ||
Price/Operating Cash Flow | -137 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 03/28/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue